Better Therapeutics, Inc. Common Stock
BTTX
BTTX was delisted on the 15th of March, 2024.
27 hedge funds and large institutions have $32.9M invested in Better Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 8 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
4% more funds holding
Funds holding: 26 → 27 (+1)
20% less capital invested
Capital invested by funds: $40.9M → $32.9M (-$8.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.64M |
| 2 |
SV
Starboard Value
New York
|
+$2.98M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.21M |
| 4 |
MSU
Mizuho Securities USA
New York
|
+$945K |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
+$497K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$4.25M |
| 2 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$3.47M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.47M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.99M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.49M |
BTTX Hedge Fund Activity: Q3 2021 in Review
27 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Better Therapeutics, Inc. Common Stock (BTTX) for Q3 2021, worth a combined $32.9M — down 20% from $40.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BTTX positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $4.64M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $4.25M sold.
- 27 institutional investors held Better Therapeutics, Inc. Common Stock (BTTX) as of Q3 2021, up from 26 in Q2 2021.
- Funds reported $32.9M of Better Therapeutics, Inc. Common Stock stock for Q3 2021, down 20% quarter-over-quarter.
- 9 funds opened new Better Therapeutics, Inc. Common Stock positions in Q3 2021 and 8 closed out, a net change of +1 holder.
- The largest Better Therapeutics, Inc. Common Stock buyer in Q3 2021 was Sectoral Asset Management, an estimated $4.64M added.
- The largest Better Therapeutics, Inc. Common Stock seller in Q3 2021 was Boothbay Fund Management, an estimated $4.25M sold.
Based on aggregated 13F filings for Q3 2021.